Peers & Perspectives

Experts discuss prevalence of insomnia, its co-occurrence with other health conditions, treatment considerations and data with dual orexin receptor antagonists, the newest therapeutic class in the treatment of insomnia. They also emphasize the importance of improving awareness of insomnia and other sleep disorders in various patient populations.

Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, PMHNP-BC, FNP-BC, GNP-BC, NP-C, CNE, CNEcl, CARN-AP, have a discussion on the considerations of treating schizophrenia, the use of long acting injectables, and how to connect with patients to increase medication adherence.

Perspectives in Insomnia

Key opinion leaders in sleep disorders discuss practical implications and clinical characteristics of insomnia focusing on treatment and management considerations.